로딩 중…
지수 로딩 중…
Veraxa Biotech AG Ordinary Shares
VRXA· NASDAQ· Health Care
$1.65+0.00%
2026-09-11
Valuation Metrics
Veraxa Biotech AG Ordinary Shares's Market Cap is $225M. Ranked #3006 of 3,118 in US market (top 96%), #1372 of 1,460 on NASDAQ (top 94%) by Market Cap.
Investment Metrics(as of 2026-09-11)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $225M | US#3,006/3,118 |
| Employees | 8 | US#2,796/3,118 |
| Performance | ||
| 1M Return | -12.70% | US#2,593/3,118 |
| From 52W High | -93.97% | US#3,122/3,118 |
| 1Y MDD | -94.55% | US#3,123/3,118 |
| Trading | ||
| Volume | 88,569 shares | US#2,147/3,118 |
| Trading Value | $147024.00 | US#3,066/3,118 |
Company Info
Veraxa Biotech Holding AG is a clinical-stage biopharmaceutical company, formed via a merger with Voyager Acquisition Corp., focusing on developing next-generation cancer therapies such as antibody-drug conjugates (ADCs) and bispecific T-cell engagers. [64, 65]